CN1525864A - 具有免疫增强特性的粘蛋白肽 - Google Patents

具有免疫增强特性的粘蛋白肽 Download PDF

Info

Publication number
CN1525864A
CN1525864A CNA028077784A CN02807778A CN1525864A CN 1525864 A CN1525864 A CN 1525864A CN A028077784 A CNA028077784 A CN A028077784A CN 02807778 A CN02807778 A CN 02807778A CN 1525864 A CN1525864 A CN 1525864A
Authority
CN
China
Prior art keywords
cells
peptide
sec
tumor
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028077784A
Other languages
English (en)
Chinese (zh)
Inventor
�찲�ȡ�M������˹
黛安娜·M·洛佩斯
ղ���
林恩·赫伯特
小曼特利·多尔西
甘特·克劳斯
��H���ɵ���
詹姆斯·H·纳蒂欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of CN1525864A publication Critical patent/CN1525864A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CNA028077784A 2001-04-02 2002-04-02 具有免疫增强特性的粘蛋白肽 Pending CN1525864A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28013701P 2001-04-02 2001-04-02
US60/280,137 2001-04-02

Publications (1)

Publication Number Publication Date
CN1525864A true CN1525864A (zh) 2004-09-01

Family

ID=23071833

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028077784A Pending CN1525864A (zh) 2001-04-02 2002-04-02 具有免疫增强特性的粘蛋白肽

Country Status (11)

Country Link
US (2) US7285282B2 (enExample)
EP (1) EP1372691B1 (enExample)
JP (2) JP4223813B2 (enExample)
KR (1) KR20030092044A (enExample)
CN (1) CN1525864A (enExample)
AT (1) ATE376836T1 (enExample)
BR (1) BR0208771A (enExample)
CA (1) CA2443045A1 (enExample)
DE (1) DE60223232T2 (enExample)
NZ (1) NZ528234A (enExample)
WO (1) WO2002078607A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301267C (zh) * 2005-06-21 2007-02-21 中国人民解放军军事医学科学院附属医院 Muc1粘蛋白的一个模拟表位肽及其编码dna与应用
CN112574283A (zh) * 2020-12-07 2021-03-30 湖北文理学院 一种人muc1特异性结合多肽及其提取方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008093166A2 (en) * 2006-05-11 2008-08-07 Ghent University Sialoadhesin-related compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668064B1 (fr) * 1990-10-23 1994-12-16 Transgene Sa Composition pharmaceutique pour le traitement ou la prevention d'une tumeur maligne.

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301267C (zh) * 2005-06-21 2007-02-21 中国人民解放军军事医学科学院附属医院 Muc1粘蛋白的一个模拟表位肽及其编码dna与应用
CN112574283A (zh) * 2020-12-07 2021-03-30 湖北文理学院 一种人muc1特异性结合多肽及其提取方法
CN112574283B (zh) * 2020-12-07 2022-07-05 湖北文理学院 一种人muc1特异性结合多肽及其提取方法

Also Published As

Publication number Publication date
US7285282B2 (en) 2007-10-23
US20050095675A1 (en) 2005-05-05
DE60223232T2 (de) 2008-08-14
JP4223813B2 (ja) 2009-02-12
EP1372691A2 (en) 2004-01-02
JP2004532018A (ja) 2004-10-21
WO2002078607A2 (en) 2002-10-10
EP1372691B1 (en) 2007-10-31
BR0208771A (pt) 2004-07-06
WO2002078607A3 (en) 2003-03-27
ATE376836T1 (de) 2007-11-15
NZ528234A (en) 2006-01-27
JP2005247861A (ja) 2005-09-15
EP1372691A4 (en) 2005-11-09
CA2443045A1 (en) 2002-10-10
KR20030092044A (ko) 2003-12-03
US20030166853A1 (en) 2003-09-04
DE60223232D1 (de) 2007-12-13

Similar Documents

Publication Publication Date Title
CN102112146B (zh) 免疫诱导剂
CN1281625C (zh) 经修饰的wt1肽
US7446185B2 (en) Her2/neu target antigen and use of same to stimulate an immune response
JP6042802B2 (ja) 新生物（腫瘍）を治療するための免疫原性組成物及び方法。
ES2373055T3 (es) Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
CN1291755C (zh) 增强低免疫原性抗原的免疫原性的药物组合物
US8748170B2 (en) Polypeptides derived from cyclin B1 and uses thereof
CZ20011521A3 (cs) Farmaceutický prostředek obsahující fragmenty DNA kódující antigenní protein vykazující protinádorový účinek
JP2013047230A (ja) Ｈｌａ−ａ２陽性者用ｈｓｐ１０５由来癌拒絶抗原ペプチド及びこれを含む医薬
CN1525864A (zh) 具有免疫增强特性的粘蛋白肽
Weng et al. A unique MUC1-2-VNTR DNA vaccine suppresses tumor growth and prolongs survival in a murine multiple myeloma model
AU2002304165B9 (en) Polynucleotide vaccine
EP1579870B1 (en) Vaccines comprising polynucleotides
WO2024052542A2 (en) A peptide cocktail
JP7160462B2 (ja) 免疫誘導剤
AU2002307032A1 (en) Mucin peptide with immunoenhancing properties
HK1040403A1 (zh) 来源於sart-1的肿瘤抗原肽
HK1063726B (en) Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
HK1070078B (en) Wt1 modified peptide

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication